Lilly, a global healthcare leader, is offering an exciting opportunity for aspiring data and analytics professionals to join as an Intern – IBU Analytics in Bengaluru, Karnataka. This internship will provide hands-on experience in business intelligence, data visualization, and analytics within the healthcare domain.
If you’re passionate about data-driven decision-making, business intelligence, and pharmaceutical analytics, this role is designed to help you grow your skills while contributing to life-changing healthcare solutions.
🔑 Key Responsibilities
As an IBU Analytics Intern at Lilly, you will:
- Deliver accurate and timely data reporting and visualization.
- Build expertise in NE Hub datasets for customer-focused insights.
- Ensure data quality via validation, monitoring, and root cause analysis.
- Design and maintain Power BI dashboards for KPIs like sales, growth, market share, and engagement.
- Provide descriptive analytics to support segmentation and performance tracking.
- Contribute to all phases of analytics projects, from kick-off to presentation.
- Meet SLAs and address internal stakeholder queries.
🎓 Qualifications & Experience
Education
- Bachelor’s or Master’s in Finance, Statistics, Econometrics, Engineering, Computer Science, or related field.
- Pharma/healthcare industry experience is an advantage.
Experience
- 1–2 years in data management, BI, market intelligence, reporting, or descriptive analytics.
- Ability to work with complex datasets to generate actionable insights.
Technical Skills
- Advanced SQL (querying, debugging).
- Power BI (dashboard design & development).
- MS Excel (advanced formulas, pivots, lookups) and PowerPoint.
- Coding in Python/R; VBA knowledge is a plus.
- Familiarity with pharma databases is an advantage.
💡 Benefits of Joining Lilly
- Gain exposure to global healthcare analytics.
- Opportunity to work on real-world pharma datasets.
- Enhance technical skills in Power BI, SQL, and Python.
- Collaborate with an experienced BI & Analytics team.
- Valuable internship experience with a leading global pharma company.
